CLINICAL_TRIALS
research
· 2025-06-10
Clinical Trial Update: A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia [EARLY_Phase 1]
Summary
This entry notes an early Phase 1 trial at Peking University testing adjunctive thyroxine for avolition in schizophrenia, with the study not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University | Conditions: Schizophrenia, Avolition | EARLY_Phase 1 | Status: NOT_YET_RECRUITING